ID: ALA5269646

Max Phase: Preclinical

Molecular Formula: C26H22N2O2

Molecular Weight: 394.47

Associated Items:

Representations

Canonical SMILES:  CN(Cc1cccc(-c2ccncc2)c1)C(=O)Oc1ccc(-c2ccccc2)cc1

Standard InChI:  InChI=1S/C26H22N2O2/c1-28(19-20-6-5-9-24(18-20)23-14-16-27-17-15-23)26(29)30-25-12-10-22(11-13-25)21-7-3-2-4-8-21/h2-18H,19H2,1H3

Standard InChI Key:  CDDYEXHMEHZNPY-UHFFFAOYSA-N

Associated Targets(Human)

Monoacylglycerol lipase ABHD6 331 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 394.47Molecular Weight (Monoisotopic): 394.1681AlogP: 6.05#Rotatable Bonds: 5
Polar Surface Area: 42.43Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.06CX LogP: 5.50CX LogD: 5.49
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.41Np Likeness Score: -0.83

References

1. Deng H, Li W..  (2020)  Therapeutic potential of targeting α/β-Hydrolase domain-containing 6 (ABHD6).,  198  [PMID:32371333] [10.1016/j.ejmech.2020.112353]

Source